VRTX
$VRTX
Vertex Pharmaceuticals
Biotech leader in cystic fibrosis treatments and pain therapies.
Healthcare$530.76
-22.39 (-4.05%)
Day Range$529.15 - $561.96
Prev Close$553.15
Analyst Rating
Strong Buy
26 Buy / 4 Hold / 2 Sell
Price Target
$580.20
9.3% upside
Subscribers
1
Tracking this ticker
Latest Report
Analysis from Oct 31, 2026
VRTX: Vertex Near Highs, Growth vs Tight Upside
Vertex (VRTX) carries high-quality CF franchises and expanding gene therapy revenues, yet it trades near its highs with limited analyst-implied upside. Upcoming Q3 results and guidance will be key for assessing forward growth versus valuation.
Oct 31, 2026
Previous Reports
Keep exploring
- draft Vertex Pharmaceuticals into a free practice contest: How to put the stock you just researched into a contest lineup at no real-money risk
- the healthcare sector brief for context on Vertex Pharmaceuticals's peers: Today's sector-level news and moves around the stock